JPRN-UMIN000044500已完成未知
Immunogenicity and safety of BNT162b2 mRNA vaccine in outpatients on dialysis: Double center prospective observational study in Japan - Immunogenicity and safety of BNT162b2 mRNA vaccine in outpatients on dialysis: Double center prospective observational study in Japan
Shonan Fujisiawa Tokushukai Hospital0 个研究点目标入组 150 人开始时间: 2021年6月11日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 150
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 16years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •aged <16 years being infected SARS-CoV-2 and in isolation having already received the vaccine not wishing to be vaccinated by their own choice or on the recommendation of their physician; and did not provide informed consent.
研究者
相似试验
尚未招募
不适用
Immunogenicity of 2 dose regimen of BNT162b2 mRNA vaccine in Thai children aged 6 months to 4 years following COVID 19 (COVID-19)Prevention of COVID-19 with 2-dose mRNA vaccine among healthy Children 6 month to 4 years who had COVID-19 infectionSARS-CoV-2, mRNA vaccine, Infant, Children, Immunogenicity, ReactogenicityTCTR20221018008Ratchadaphisek Sompoch Research Fund80
尚未招募
3 期
Immunogenicity and safety after vaccinated with BBIBP-CorV (COVID-19 vaccine) in Thai pregnant womePregnant womenCOVID-19SARS-CoV-2 vaccineVaccinePregnantBBIBP-CorVSinopharmTCTR20210923013Chulabhorn Hospital400
已完成
不适用
Covid-19 Vaccine Response in Elderly SubjectsCovid19 VaccineNCT04760704University Hospital, Lille264
已完成
不适用
Safety and Effectiveness of MVA-BN vaccination against MPXV infection in at-risk individuals in GermanySafety and Effectiveness of MVA-BN vaccination against MPXV infection in at-risk individuals in GermanyB04MonkeypoxDRKS00029638Charité - Universitätsmedizin Berlin15,813
已完成
2 期
Study of HPV Vaccine adverse events and protection in patients with Juvenile Lupus and Juvenile DermatomyositisJuvenile DermatomyositisRBR-9ypbtfCoordenação de Aperfeiçoamento de Pessoal de Nível Superior